| Overview |
| bs-2644R-PE-Cy5.5 |
| CD158i Polyclonal Antibody, PE-Cy5.5 Conjugated |
| WB |
| Human |
| Specifications |
| PE-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CD158i |
| 221-290/290 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3809 |
| P43632 |
| Cell membrane |
| KKA3; KIR1D; NKAT8; CD158I; KIR412; NKAT-8; KIR2DS1; Killer cell immunoglobulin-like receptor 2DS4; CD158 antigen-like family member I; MHC class I NK cell receptor; Natural killer-associated transcript 8; P58 natural killer cell receptor clones CL-39/CL-17; p58 NK receptor CL-39/CL-17; KIR2DS4 |
| Receptor on natural killer (NK) cells for HLA-C alleles. Does not inhibit the activity of NK cells. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz